These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12113190)

  • 1. Taking ACE inhibitors during pregnancy. Is it safe?
    Ratnapalan S; Koren G
    Can Fam Physician; 2002 Jun; 48():1047-9. PubMed ID: 12113190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal neonatal renal failure due to maternal enalapril ingestion.
    Murki S; Kumar P; Dutta S; Narang A
    J Matern Fetal Neonatal Med; 2005 Mar; 17(3):235-7. PubMed ID: 16147831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits.
    Pucci M; Sarween N; Knox E; Lipkin G; Martin U
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):221-31. PubMed ID: 25612630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(11):240-2. PubMed ID: 9082178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment.
    Tabacova S; Little R; Tsong Y; Vega A; Kimmel CA
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):633-46. PubMed ID: 14762979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
    Quan A
    Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal anuria by ACE inhibitors during pregnancy.
    Lavoratti G; Seracini D; Fiorini P; Cocchi C; Materassi M; Donzelli G; Pela I
    Nephron; 1997; 76(2):235-6. PubMed ID: 9200422
    [No Abstract]   [Full Text] [Related]  

  • 8. Taking angiotensin-converting enzyme inhibitors during pregnancy: is it safe?
    Al-Maawali A; Walfisch A; Koren G
    Can Fam Physician; 2012 Jan; 58(1):49-51. PubMed ID: 22267620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibitors in pregnancy--how to avoid the sting in the tail.
    Opie LH
    S Afr Med J; 1996 Apr; 86(4):326-7. PubMed ID: 8693361
    [No Abstract]   [Full Text] [Related]  

  • 10. Major congenital malformations after first-trimester exposure to ACE inhibitors.
    Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
    N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ACE inhibition on the fetal kidney: decreased renal blood flow.
    Martin RA; Jones KL; Mendoza A; Barr M; Benirschke K
    Teratology; 1992 Oct; 46(4):317-21. PubMed ID: 1412062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are ACE inhibitors safe in pregnancy?
    Lancet; 1989 Aug; 2(8661):482-3. PubMed ID: 2570189
    [No Abstract]   [Full Text] [Related]  

  • 13. ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection.
    Barr M; Cohen MM
    Teratology; 1991 Nov; 44(5):485-95. PubMed ID: 1771591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors in pregnancy may result in neonatal renal failure.
    Hulton SA; Thomson PD; Cooper PA; Rothberg AD
    S Afr Med J; 1990 Dec; 78(11):673-6. PubMed ID: 2251614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal anuria with maternal angiotensin-converting enzyme inhibition.
    Rosa FW; Bosco LA; Graham CF; Milstien JB; Dreis M; Creamer J
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):371-4. PubMed ID: 2761913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition and management of angiotensin converting enzyme inhibitor fetopathy.
    Sedman AB; Kershaw DB; Bunchman TE
    Pediatr Nephrol; 1995 Jun; 9(3):382-5. PubMed ID: 7632538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors.
    Brent RL; Beckman DA
    Teratology; 1991 Jun; 43(6):543-6. PubMed ID: 1882342
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
    Cooper WO
    J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged exposure to angiotensin-converting enzyme inhibitors during pregnancy. Fetal toxicity could be reversible.
    Shrim A; Berger H; Kingdom J; Hamoudi A; Shah PS; Koren G
    Can Fam Physician; 2005 Oct; 51(10):1335-7. PubMed ID: 16250418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
    Schaefer C
    Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.